(Q39974472)

English

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nadia Warner

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Stephen Locarnini

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

88-98

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute leukaemia in chronic hepatitis B patients with lamivudine therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational analysis of hepatitis B surface antigen particle assembly and secretion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the carboxyl-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoassay detection of hepatitis B surface antigen mutants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivator

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and virological mechanisms of HBV drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of early hepatitis B virus surface protein oligomers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of envelope proteins in hepatitis B virus assembly

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of host cellular multivesicular body functions in hepatitis B virus budding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of N Glycosylation of Hepatitis B Virus Envelope Proteins in Morphogenesis and Infectivity of Hepatitis Delta Virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttranslational N-glycosylation of the hepatitis B virus large envelope protein.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22295

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22295

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39974472&oldid=1881637048"